Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
FDA Accepts Application for Roche’s Faricimab for the Treatment of Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration […]
Theme Park Joins NHS Covid Vaccine Drive
Thorpe Park Resort will today (Thursday) join the roll-call of iconic locations to take part […]
AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases
AbbVie (NYSE: ABBV) and Calico Life Sciences today announced an extension of their leading-edge collaboration […]
Medtronic TYRX ™ Absorbable Antibacterial Envelope Is Effective at Reducing Infections in Cardiac Device Patients with Hematomas
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced new data from […]
Avatar-led Programme for Kidney Disease Patients Expands After Successful Pilot
An avatar-led, interactive, information programme for people with Chronic Kidney Disease (CKD) has been so […]
Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of the Prevail™ […]
GNTbm's Trial on New Epigenetic Drug Generates Hope for Patients with Breast Cancer
Breast cancer is the most common cancer in women worldwide, especially in Taiwan. In 2018, Taiwan recorded 14,127 […]
Implicity Launches a Solution to Improve Remote Monitoring of Heart Failure Patients
Implicity, a leader in remote patient monitoring software and cardiac data management solutions, announced the […]
Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of Covid-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government […]
Chelsea and Westminster Launch Acute Covid App for NHS Staff
Acute Covid was developed as part of the CW Innovation programme, which has been fast-tracking […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more